Equities research analysts predict that IntriCon Co. (NASDAQ:IIN) will post $28.18 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for IntriCon’s earnings, with estimates ranging from $28.10 million to $28.26 million. IntriCon reported sales of $30.13 million during the same quarter last year, which indicates a negative year-over-year growth rate of 6.5%. The business is scheduled to report its next earnings results on Monday, November 4th.

According to Zacks, analysts expect that IntriCon will report full year sales of $116.19 million for the current financial year, with estimates ranging from $116.17 million to $116.20 million. For the next fiscal year, analysts anticipate that the company will post sales of $130.09 million, with estimates ranging from $130.00 million to $130.18 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that follow IntriCon.

IntriCon (NASDAQ:IIN) last announced its quarterly earnings data on Tuesday, August 6th. The technology company reported ($0.57) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.02 by ($0.59). The company had revenue of $29.34 million during the quarter, compared to analyst estimates of $29.32 million. IntriCon had a negative net margin of 1.23% and a positive return on equity of 4.21%.

IIN has been the topic of several research reports. Zacks Investment Research upgraded shares of IntriCon from a “sell” rating to a “hold” rating in a report on Saturday, August 3rd. Stifel Nicolaus set a $36.00 price target on shares of IntriCon and gave the company a “buy” rating in a research note on Friday, July 19th. ValuEngine upgraded shares of IntriCon from a “buy” rating to a “strong-buy” rating in a research note on Thursday, September 5th. Finally, B. Riley set a $36.00 price objective on shares of IntriCon and gave the company a “buy” rating in a report on Wednesday, August 7th. Two investment analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. IntriCon has a consensus rating of “Buy” and an average target price of $38.75.

Large investors have recently modified their holdings of the company. Emerald Mutual Fund Advisers Trust acquired a new position in shares of IntriCon in the 1st quarter valued at $4,399,000. Marshall Wace North America L.P. increased its position in IntriCon by 719.3% during the 2nd quarter. Marshall Wace North America L.P. now owns 117,610 shares of the technology company’s stock worth $2,747,000 after purchasing an additional 103,255 shares in the last quarter. Marshall Wace LLP raised its position in shares of IntriCon by 51.4% in the 1st quarter. Marshall Wace LLP now owns 244,688 shares of the technology company’s stock valued at $6,137,000 after purchasing an additional 83,103 shares in the last quarter. Roubaix Capital LLC boosted its stake in shares of IntriCon by 141.8% during the 2nd quarter. Roubaix Capital LLC now owns 141,301 shares of the technology company’s stock valued at $3,301,000 after buying an additional 82,867 shares during the last quarter. Finally, Gamco Investors INC. ET AL boosted its stake in shares of IntriCon by 288.1% during the 2nd quarter. Gamco Investors INC. ET AL now owns 93,919 shares of the technology company’s stock valued at $2,194,000 after buying an additional 69,719 shares during the last quarter. 77.66% of the stock is owned by hedge funds and other institutional investors.

NASDAQ:IIN traded up $0.69 on Friday, hitting $20.93. 66,710 shares of the company’s stock were exchanged, compared to its average volume of 149,310. The firm has a 50-day moving average price of $17.95 and a 200-day moving average price of $22.65. IntriCon has a 52 week low of $16.81 and a 52 week high of $68.15. The company has a debt-to-equity ratio of 0.03, a current ratio of 3.02 and a quick ratio of 2.19. The company has a market cap of $179.93 million, a P/E ratio of 32.70, a price-to-earnings-growth ratio of 7.44 and a beta of 0.72.

IntriCon Company Profile

IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical biotelemetry devices, hearing healthcare, and professional audio communication devices markets.

Featured Story: Trade War

Get a free copy of the Zacks research report on IntriCon (IIN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for IntriCon (NASDAQ:IIN)

Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.